HUY G NGUYEN
Dr Huy Gia Nguyen is an early-career biomedical engineer and artificial intelligence researcher whose work bridges osteoporosis, musculoskeletal imaging, multimorbidity, and population-health data science. His research addresses a critical gap in secondary fracture prevention: although many patients remain at high risk of subsequent fracture and death after an index fragility fracture, routinely collected health data are rarely used systematically to identify those at greatest need of intervention.
Dr Nguyen is currently a Research Officer at the Garvan Institute of Medical Research, where he develops predictive models for fracture, mortality, and hospital-admission outcomes using large-scale linked population health data from New South Wales. His methodological expertise spans deep learning, computer vision, survival analysis, and epidemiology, with a sustained clinical focus on osteoporosis detection, risk stratification, and post-fracture care.
He completed his PhD in Biomedical Engineering at the University of Technology Sydney in 2025. His thesis, Identification of Asymptomatic Vertebral Fractures Using Artificial Intelligence Methods, developed AI-driven approaches for vertebral fracture detection and bone-density estimation from standard radiographs. Extending this imaging-based foundation, his current work now moves into linked-data modelling of multimorbidity and comorbidity trajectories before and after fracture. This approach seeks to improve prediction of imminent refracture and mortality while clarifying how underlying health status shapes adverse post-fracture outcomes—offering a meaningful advance over treating comorbidities as static baseline variables.
Dr Nguyen has built a focused early-career publication profile in AI-enabled musculoskeletal research. His first-author work has advanced radiograph-based bone-density estimation and asymptomatic vertebral fracture detection, while his collaborative research spans fracture genetics, sarcopenia, osteoarthritis, thyroid cancer, and fall-risk assessment-demonstrating his capacity to work across imaging, clinical, and epidemiological datasets. As of September 2026, he holds an h-index of 7 and an i10-index of 6.
Abstracts this author is presenting: